$ENLV Balance Sheet | Understand Stock

$ENLV

$0.16 -$0.01 (6.17%) Close

$ENLV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014
Current Assets
Cash and cash equivalents (note 3)
Short term deposits (note 4)
Receivables and prepaid expenses
Prepaid expenses
Other receivables
Cash held with respect to CVR Agreement (notes 1a,3)
Short-term interest-bearing deposits (note 4)
Prepaid expenses and other receivables (note 5)
Restricted cash
Cash held with respect to CVR Agreement (notes 3,8)
Cash held with respect to CVR Agreement (notes 3 & 8)
Assets classified as held for sale (note 18)
Digital assets, at fair value (note 6)
Digital assets purchase option (note7)

Total Current Assets
Non-Current Assets
Long-term assets
Restricted cash (notes 2e, 3)
Long-term prepaid expenses
Property and equipment, net (note 8)
Other assets (notes 7 & 9)
Digital assets, at fair value (note 6)
Other assets (note 9)

Total Non-Current Assets
TOTAL ASSETS
Current Liabilities
Accounts payable trade
Other accounts payable
Accrued expenses and other liabilities (note 8)
Payables to related parties (note 13)
CVR holders (note 1a)
CVR holders (note 8)
Accrued expenses and other liabilities (note 10)
Liability classified as held for sale (note 18)

Total Current Liabilities
LONG-TERM LIABILITIES
Non-Current Liabilities
Retirement benefit obligations (note 2j)
Deferred tax liability
Lease liabilities (note 11)

Total Non-Current Liabilities
TOTAL LIABILITIES
SHAREHOLDERS’ EQUITY
Ordinary shares of NIS 0.40 par value: (note 13) Authorized: 500,000,000 and 45,000,000 shares as of December 31, 2025 and 2024, respectively; Issued and outstanding: 237,381,498 and 23,650,989 as of December 31, 2025 and 2024, respectively;
Preferred stock
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Additional paid in capital
Foreign currency translation reserve
Accumulated other comprehensive income
Retained earnings (accumulated deficit)

TOTAL SHAREHOLDERS’ EQUITY
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Comments